Neoindicate
Wellington, US · 1 known investors
Find your way into Neoindicate
Sign up to see every warm intro you have to Neoindicate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neoindicate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
Investors · 1
Frequently asked questions
- What does Neoindicate do?
- Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
- Who are Neoindicate's investors?
- Neoindicate's investors include CWRU Technology Ventures.
- Where is Neoindicate headquartered?
- Neoindicate is headquartered in Wellington, US.